NCT06006624View on ClinicalTrials.gov

Exparel vs Block for ACL Reconstruction

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

August 21, 2023

Primary Completion Date

October 30, 2024

Study Completion Date

October 30, 2024

Conditions
ACLPostoperative Pain
Interventions
DRUG

Exparel 30 mL

30 mL Liposomal bupivacaine (Exparel) evenly distributed and administered in adductor canal block

DRUG

0.5% bupivacaine

5 cc's of 0.5% bupivacaine evenly distributed and administered in adductor canal

DRUG

Dexamethasone

10 mg preservative free Dexamethasone evenly distributed and administered in adductor canal

DRUG

iPACK block

iPACK (Infiltration between the Popliteal artery and Capsule of the Knee) block

Trial Locations (1)

19107

Rothman Orthopaedic Institute, Philadelphia

All Listed Sponsors
lead

Rothman Institute Orthopaedics

OTHER